| Model Number |
6900PTFX29 |
| Medical Device Problem Codes |
Fluid/Blood Leak (1250); Gradient Increase (1270)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
01/03/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that a patient with a 29mm 6900ptfx pericardial mitral valve was placed under consideration for a valve-in-valve procedure after an implant duration of six (6) years, five (5) months due to mitral stenosis and regurgitation.
|
| |
|
Additional Manufacturer Narrative
|
|
The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
| |
|
Additional Manufacturer Narrative
|
|
The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Stenosis, which develops progressively over time, can be due to a number of issues.Additionally, there can be a number of potential known and unknown patient-related contributing factors.Structural valve deterioration (svd) is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes, occurring singularly or concomitantly, may contribute to stenosis and/or regurgitation.Alternatively, non-structural valve dysfunction (nsvd) may also play a role in the development of valvular stenosis.Stenosis is most commonly related to patient factors and is not usually an indication of a device malfunction.
|
| |
|
Event or Problem Description
|
|
It was reported that a patient with a 29mm 6900ptfx pericardial mitral valve underwent a valve-in-valve procedure after an implant duration of six (6) years, six (6) months due to mitral stenosis and regurgitation.The tmvr procedure was performed with a 29mm 9600tfx transcatheter valve.
|
| |
|
Search Alerts/Recalls
|